SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549
 
FORM 10-QSB
 
|X| QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES
 
EXCHANGE ACT OF 1934
 
For the quarterly period ended August 31, 2007
 
|_| TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
 
For the transition period from ________ to________
 
Commission file number 333-108632
 
NARROWSTEP INC.
 
(Exact name of small business issuer as specified in its charter)

DELAWARE
33-1010941
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

116 Village Blvd, Suite 200
Princeton, New Jersey 08540
United States
(Address of principal executive offices)
 
(609) 951-2221
(Issuer’s telephone number)
 
Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes |X| No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

|_| Yes |X| No
 
State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 125,280,977 s hares of common stock, $0.000001 par value.



PART 1 - FINANCIAL INFORMATION
         
Item 1 - Financial Statements
         
           
NARROWSTEP INC. AND SUBSIDIARIES
         
CONDENSED CONSOLIDATED BALANCE SHEETS
         
 
 
August 31, 2007
 
February 28, 2007
 
   
(Unaudited)
     
 
 
$
 
$
 
Assets
             
               
Current assets:
             
Cash and cash equivalents
   
10,170,561
   
466,870
 
Accounts receivable, net of allowance for doubtful accounts
   
1,211,993
   
1,403,779
 
   of $1,574,090 and $940,534, respectively
             
Prepaid expenses and other current assets
   
420,672
   
332,192
 
               
Total current assets
   
11,803,226
   
2,202,841
 
Property and equipment, net
   
2,677,606
   
1,234,557
 
Software development costs, net
   
244,574
   
149,080
 
               
Total Assets
   
14,725,406
   
3,586,478
 
               
Liabilities and Stockholders' Equity
             
Liabilities
             
Current liabilities:
             
Unearned revenue
   
191,004
   
384,295
 
Accounts payable
   
877,672
   
960,580
 
Net obligations under capital leases, current
   
151,058
   
88,110
 
Accrued expenses and other current liabilities
   
844,140
   
977,948
 
Total current liabilities
   
2,063,874
   
2,410,933
 
Net obligations under capital leases, long-term
   
217,355
   
135,470
 
Total Liabilities
   
2,281,229
   
2,546,403
 
               
Commitments and Contingencies
             
Stockholders' Equity
             
Common stock, $0.000001 par value 450,000,000 shares authorized,
   
125
   
45
 
125,280,977  issued and outstanding at August 31, 2007 and
             
45,348,974  issued and outstanding at February 28, 2007
             
Additional paid-in capital
   
40,093,676
   
20,543,688
 
Accumulated deficit
    (27,737,934 )   (19,555,533 )
Accumulated other comprehensive income
   
88,310
   
51,875
 
               
Total Stockholders' Equity
   
12,444,177
   
1,040,075
 
               
Total Liabilities and Stockholders' Equity
   
14,725,406
   
3,586,478
 
               
See Notes to Condensed Consolidated Financial Statements.
             

 
2

 
         
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
         
AND COMPREHENSIVE LOSS (Unaudited)
         
   
Three Months Ended
 
Six Months Ended
 
   
August 31, 2007
 
August 31, 2006
 
August 31, 2007
 
August 31, 2006
 
   
$
 
$
 
$
 
$
 
Revenue
                 
Narrowcasting and other
   
1,143,955
   
1,041,980
   
2,559,115
   
1,878,493
 
Production services
   
141,902
   
526,387
   
317,535
   
834,397
 
                           
Total revenue
   
1,285,857
   
1,568,367
   
2,876,650
   
2,712,890
 
                           
Costs and Expenses
                         
                           
Operating
   
1,361,524
   
711,085
   
2,587,315
   
1,133,303
 
                           
Selling, general and administrative
   
3,449,202
   
1,900,687
   
6,094,826
   
3,581,250
 
                           
Research & development
   
783,298
   
285,093
   
1,582,048
   
540,150
 
                           
Total operating expenses
   
5,594,024
   
2,896,865
   
10,264,189
   
5,254,703
 
                           
Operating Loss
    (4,308,167 )   (1,328,498 )   (7,387,539 )   (2,541,813 )
                           
Interest income (expense), net
    (599,280 )  
41,166
    (778,923 )  
85,265
 
                           
Currency exchange income (loss)
    (14,036 )  
1,745
    (15,939 )  
1,156
 
                           
Net Loss
    (4,921,483 )   (1,285,587 )   (8,182,401 )   (2,455,392 )
                           
Foreign currency translation adjustment
   
18,963
   
6,219
   
36,435
   
42,983
 
                           
Comprehensive Loss
    (4,902,520 )   (1,279,368 )   (8,145,966 )   (2,412,409 )
                           
Net Loss per Common Share - Basic and Diluted
    (0.07 )   (0.03 )   (0.14 )   (0.05 )
                           
Weighted-Average Number of Shares Outstanding, Basic and Diluted
   
67,858,410
   
45,248,974
   
56,603,692
   
45,192,724
 
                           
See Notes to Condensed Consolidated Financial Statements.
                         



3




           
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
           
(Unaudited)
            
 
 
Six Months Ended
 
   
August 31, 2007
   
August 31, 2006
 
 
 
$
   
$
 
Cash Flows from Operating Activities
               
Net loss
    (8,182,401 )     (2,455,392 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
                 
Allowance for doubtful accounts
   
633,556
     
53,904
 
Depreciation and amortization
   
439,978
     
255,126
 
Stock-based compensation expense
   
1,619,270
     
814,497
 
Interest on short-term investment
   
-
      (57,609 )
                 
Fair value of options and warrants granted to third party suppliers
   
19,625
     
-
 
                 
Interest on debt issuance
   
853,200
     
-
 
Changes in net cash attributable to changes in operating assets and liabilities:
               
Accounts receivable, gross
    (441,770 )     (970,495 )
Prepaid expenses and other current assets
    (88,480 )     (73,705 )
                 
Unearned revenue
    (193,291 )    
214,457
 
Accounts payable, accrued expenses and other current liabilities
    (216,716 )    
463,307
 
                 
Net Cash Used in Operating Activities
    (5,557,029 )     (1,755,910 )
                 
Cash Flows from Investing Activities
               
Purchases of property and equipment
    (1,583,660 )     (580,675 )
Payments for software development costs
    (141,588 )     (79,001 )
                 
Net Cash Provided by (Used in) Investing Activities
    (1,725,248 )     (659,676 )
                 
Cash Flows from Financing Activities
               
                 
Net proceeds from issuance of common stock
   
10,127,457
     
1,379,403
 
                 
Proceeds from exercise of stock options and warrants
   
-
     
6,250
 
Payments on capital leases
    (42,998 )     (33,537 )
                 
Net Proceeds from issuance of debt instrument
   
6,950,130
     
-
 
                 
Net Cash Provided by Financing Activities
   
17,034,589
     
1,352,116
 
                 
Net Increase (Decrease) in Cash and Cash Equivalents
   
9,752,312
      (1,063,470 )
Effect of exchange rates on change in cash
    (48,621 )    
14,098
 
Cash and cash equivalents at the beginning of period
   
466,870
     
2,232,854
 
                 
Cash and Cash Equivalents at the End of the Period
   
10,170,561
     
1,183,482
 
See Notes to Condensed Consolidated Financial Statements.
               
                 
Supplemental disclosure of non-cash investing activities:
               
Property and equipment under capital leases
   
188,781
     
133,875
 
                 
Supplemental disclosure of non-cash financing activities:
               
Debt converted to equity
   
6,950,130
     
-
 
Interest on debt issuance was paid out with  common shares
   
853,200
     
-
 

See Notes to Condensed Consolidated Financial Statements.

4

 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
  
NOTE 1. PREPARATION OF INTERIM FINANCIAL STATEMENTS
 
Basis of Presentation. Throughout this document, Narrowstep Inc. and Subsidiaries is referred to as “Narrowstep,” “we” or the “Company.” The condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. We believe that these condensed consolidated financial statements include all adjustments (consisting only of normal recurring accruals) necessary to present fairly the results for the interim periods shown. The results for the interim periods are not necessarily indicative of the results of any other interim period or for the full year.  The reader is referred to the audited consolidated financial statements and notes thereto for the year ended February 28, 2007 filed as part of Narrowstep Inc. and Subsidiaries (collectively, the “Company”) Form 10-KSB for such year.
 
Principles of Consolidation. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Our subsidiaries operate in the TV over the Internet services industry both domestically and internationally providing various services.  All intercompany transactions have been eliminated in consolidation.
 
Use of Estimates. The preparation of the interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

 
NOTE 2.  SALE OF COMMON STOCK

On August 8, 2007, we closed a private financing with a number of accredited investors for the sale of common stock and warrants for a total purchase price of $10,510,000. Pursuant to the financing we sold a total of 42,040,000 shares of common stock at a purchase price of $0.25 per share. We also issued warrants to purchase an aggregate of 21,020,000 shares of common stock at an exercise price of $0.50 per share, subject to adjustment.  The warrants are exercisable at any time on or prior to August 8, 2012.  The warrants contain customary anti-dilution provisions in the event of any stock split, reverse stock split, reclassification or recapitalization of the Company.  In addition, the exercise price and the number of shares issuable upon the exercise of the warrants are subject to adjustment on a full-ratchet basis in the event that we issue or are deemed to have issued shares of common stock at an effective purchase price of less than $0.50 per share, subject to certain exceptions.  In the financing, we issued to the placement agents warrants to purchase an aggregate of 1,706,400 shares of common stock.  Those warrants have the same terms as the warrants issued in the financing, except that the warrants issued to the placement agents have a cashless exercise right.

NOTE 3.  CONVERTIBLE NOTES PAYABLE

On March 2, 2007, the Company entered into a Purchase Agreement (the “Purchase Agreement”) with sixteen accredited investors (the “Investors”) for the sale of its 12% Mandatorily Convertible Notes (the “Notes”) and Warrants (the “Warrants”) for a total purchase price of $7,110,000.  The Notes, which mature on March 2, 2009, bear interest at 12% per annum, payable at maturity.  The Notes will mandatorily convert at a 10% discount into the securities issued by the Company in any subsequent private placement that results in gross proceeds to the Company of at least $3,000,000 or, in the event of a sale of the Company prior thereto, shares of common stock valued at a discount of 10% to the per share price to be paid in the Company sale.  The Warrants are exercisable at any time on or prior to March 2, 2012 for an aggregate of 3,555,000 shares of common stock at an exercise price of $0.60 per share, subject to adjustment.  The Company has the right to force the cash exercise of the Warrants if the common stock trades at or above $1.80 per share for at least 20 consecutive trading days.  Both the Notes and the Warrants contain customary anti-dilution provisions in the event of any stock split, reverse stock split, reclassification or recapitalization of the Company.  In connection with the August 8, 2007 financing, the Company’s $7,110,000 in outstanding mandatorily 12% convertible notes were automatically converted into an aggregate of 35,392,003 shares of common stock at a conversion price of $0.225 per share.

NOTE 4. RELATED PARTY TRANSACTIONS

Options granted to current officers. On April 30, 2007, the Company granted options to purchase 250,000 shares to Lou Holder, our Chief Technology Officer, at an exercise price of $0.68 per share.  These options vest over a three-year period and expire on April 30, 2017.
 
On June 8, 2007, Narrowstep entered into an employment Agreement with David C. McCourt who was granted 1,250,000 shares of restricted stock units which vest monthly until November 30, 2007 and 2,500,000 shares of restricted stock which vest based on meeting certain performance milestones, to be determined by the Company’s Compensation Committee.
 
5

 
NARROWSTEP INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 
Options granted to former officers.   The Company has granted options to purchase 1,000,000 shares to Steven Crowther, our former Senior Vice President and Chief Financial Officer, at an exercise price of $1.20 per share.  500,000 of these options were granted and vested on March 1, 2005 and are exercisable until February 28, 2015.  500,000 of these options were granted on August 11, 2005, 100,000 of which vested immediately and the remaining 400,000 vested on July 1, 2006. These options are exercisable until August 11, 2015. On January 17, 2006, the Company granted Steven Crowther additional options to purchase 100,000 shares, at an exercise price of $0.90 per share. 50,000 of these options vested immediately on January 17, 2006.  In connection with the Separation and General Release Agreement between us and Mr. Crowther, the period during which Mr. Crowther may exercise his vested options was extended from September 29, 2006 until June 29, 2007. These options have since expired.
 
 
Transactions with companies in which certain persons hold an interest.   Shelly Palmer, a former director of the Company, is the owner of a consulting company, SLP Productions Inc. Pursuant to an unwritten agreement between the parties, SLP Productions billed the Company $38,000 and $36,000 for fiscal year ending February 28, 2007 and February 28, 2006, respectively for consulting services.  For the six months ending, August 31, 2007 no further consulting services were performed.
 
Narrowstep Ltd. has developed a channel for LTR Consultancy. John Goedegebuure, a founder and shareholder of Narrowstep Inc., is the Managing Director and a shareholder of LTR Consultancy.  Total revenue and total receivables from LTR Consultancy for fiscal year ending February 28, 2007, was $185,480 and $53,614 respectively.  Total revenue and total receivables from LTR Consultancy for the six months ending August 31, 2007, was $42,236 and $97,807 respectively.
 
The total amount in receivables remained unpaid and was fully reserved for at August 31, 2007.
 
Pursuant to an Investor Relations Agreement with the Company, LTR Consultancy earned fees for investor relations services of $33,705, for fiscal year ended February 28, 2007.  Of these fees, $5,892 was unpaid as of August 31, 2007.
 
On May 30, 2006, the Company entered into an advisory agreement with Granahan McCourt Advisors, LLC.  David C McCourt, Chairman of the Board of Directors, Interim Chief Executive Officer and Interim Chief Operating Officer, is the beneficial owner of Granahan McCourt Advisors, LLC and Granahan McCourt Capital, LLC, a shareholder in the Company.  Pursuant to this agreement, Granahan McCourt Advisors, LLC was issued 100,000 shares of common stock on May 30, 2006 and received warrants to purchase 6,000 shares, with an exercise price equal to $0.95 per share.  Mr. McCourt became a director of the Company on June 27, 2006, was named as Chairman of the Board and interim Chief Executive Officer in December 2006 and was named interim Chief Operating Officer in June 2007.  The Company paid Granahan McCourt Advisors, LLC $80,000 for consulting services and $9,000 to cover out of pocket expenses for fiscal year ending February 28, 2007.  Mr. McCourt voluntarily terminated the advisory agreement once he became interim Chief Executive Officer and forfeited the remaining balance in the contract.
 
 
Outdoor Channel, a Narrowstep customer, began utilizing our services in May 2007.  The Chief Executive Officer and President of Outdoor Channel is Roger L. Werner Jr., a Director of Narrowstep.  We billed Outdoor Channel, $33,204 for the six months ended August 31, 2007 and the balance in accounts receivable at August 31, 2007 is $2,500.
 
In connection with our August 2007 financing, Mr. McCourt purchased 4,000,000 shares of common stock and warrants to purchase 2,000,000 shares of common stock for a total purchase price of $1,000,000.  In addition, Mr. McCourt entered into a lock up agreement pursuant to which he and certain entities controlled by him agreed for a period of nine months from August 8, 2007 not to sell, dispose or other wise transfer any shares of common stock owned by them, subject to certain exceptions.
 
NOTE 5. CONCENTRATIONS
 
 
The largest four customers in the aggregate accounted for approximately $423,000, or 33% of our revenues for the three months ended August 31, 2007 and approximately $924,000, or 32% of our revenues for the six months ended August 31, 2007. The largest four customers in the aggregate accounted for approximately $521,000, or 34% of our revenues for the three months ended August 31, 2006 and approximately $732,000, or 27% of our revenues for the six months ended August 31, 2006. The accounts receivable balance for the largest four customers was approximately $834,000 as of August 31, 2007.
 
 
NOTE 6. RECLASSIFICATION
 
The presentation of the August 31, 2006 consolidated statement of operations and comprehensive loss has been reclassified to conform to the August 31, 2007 presentation.
 
6


 
NARROWSTEP INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
NOTE 7. SUBSEQUENT EVENTS
 
On July 20, 2007 the company entered into a six year building lease with Princeton 202 Associates Limited Partnership located in New Jersey.  The initial monthly payment is approximately $28,170 with escalations every two years.  On October 3, 2007 the company entered into a four year building lease with Philips and Feeley located in London.  The initial monthly payment is approximately $8,540 with escalations every year.

On October 7, 2007, Rajan Chopra resigned as a member of the Board of Directors of Narrowstep Inc.
 
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION .

For ease of reading, Narrowstep Inc. is referred to as “Narrowstep,” “we” or the “Company” throughout this document and the names of the particular subsidiaries providing the services generally have been omitted. Narrowstep is a holding company whose subsidiaries operate in the TV over the Internet services industry both domestically and internationally providing production and distribution services and equipment. You should read this discussion in conjunction with the condensed consolidated financial statements, accompanying notes and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-KSB for the year ended February 28, 2007.
 
Consolidated revenues for the three months ended August 31, 2007 decreased by $282,510, or 18%, to $1,285,857 as compared to $1,568,367 for the three months ended August 31, 2006. Consolidated revenues for the six months ended August 31, 2007 increased by $163,760, or 6%, to $2,876,650 as compared to $2,712,890 for the six months ended August 31, 2006 as follows:
 
Narrowcasting and other revenues for the three months ended August 31, 2007 increased by $101,975, or 10%, to $1,143,955 as compared to $1,041,980 for the three months ended August 31, 2006.  Narrowcasting revenues for the six months ended August 31, 2007 increased by $680,622, or 36%, to $2,559,115 as compared to $1,878,493 for the six months ended August 31, 2006.  The increase in narrowcasting revenues resulted primarily from a net increase in customers, partially offset by sales allowances and adjustments given in the quarter.  Although narrowcasting revenues increased quarter to quarter, the rate of growth was less than in prior quarters as a result of smaller content providers churning for non-payment.  Many of these content providers are simply undercapitalized.  The Company is in the process of refocusing its sales and marketing efforts on larger, more profitable customers to whom the Company can sell a range of products and services and away from smaller content providers who have traditionally had lower margins and higher payment default rates.  Management expects that this shift in strategic focus will accelerate the Company’s revenue growth.

Production services revenues for the three months ended August 31, 2007 decreased by $384,485, or 73%, to $141,902 as compared to $526,387 for the three months ended August 31, 2006.  Production services revenues for the six months ended August 31, 2007 decreased by $516,862, or 62%, to $317,535 as compared to $834,397 for the six months ended August 31, 2006.  As previously disclosed, our strategic plan is to focus our resources on narrowscasting and to deemphasize production services as a revenue source of our business.  Consistent with this plan, revenues from this segment continue to decline as we continue to fulfill current obligations and execute on our plan to exit this business segment.

Geographical distribution of consolidated revenues:
 
     
 
Six Months Ended        
 
  August 31,    August 31,       
 
2007
 
2006
 
Percent
 
 
$
 
$
 
Change
 
United States
 
431,647
   
320,645
   
35%
 
Europe, Middle-East and Africa
 
2,388,230
   
2,313,928
   
  3%
 
Asia Pacific
 
38,559
   
59,866
   
-36%
 
Internet Sales
 
18,214
   
18,451
   
  -1%
 
Total
 
2,876,650
   
2,712,890
   
    6%
 


Consolidated costs and expenses for the three months ended August 31, 2007 increased by $2,697,159, or 93%, to $5,594,024 as compared to $2,896,865 for the three months ended August 31, 2006.  Consolidated expenses for the six months ended August 31, 2007 increased by $5,009,486, or 95%, to $10,264,189 as compared to $5,254,703 for the six months ended August 31, 2006 as follows:

Operating expenses includes the cost of bandwidth, direct labor, sub-contracted labor, consulting fees and depreciation.  For the three months ended August 31, 2007 these costs were $1,361,524, a 91%, increase over the $711,085 reported in the three months ended August 31, 2006. Operating expenses for the six months ended August 31, 2007 were $2,587,315, a 128% increase over the $1,133,303 reported in
 
7

 
NARROWSTEP INC. AND SUBSIDIARIES
 
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION .

the six months ended August 31, 2006.  The increase resulted primarily from increased headcount to meet customer support needs in our narrowcasting business and to begin building out our internal Content Delivery Network (CDN) system.  This increase was offset in part by a reduction in production expenses.  We expect that operating expenses will continue at these higher levels for the near term as we anticipate that our CDN system will not be complete until approximately the fourth quarter of this fiscal year.  However, we expect that these expenses will begin to decrease as a percentage of total revenues as we achieve more efficiency in delivering and supporting our service offerings.
 
Selling, general and administrative expenses include employee compensation and related costs for personnel engaged in marketing, direct and reseller sales support functions, the executive team and back office help. For the three months ended August 31, 2007 these costs were $3,449,202, a 81% increase over the $1,900,687 reported for the three months ended August 31, 2006.  SG&A for the six months ended August 31, 2007 costs were $6,094,826, a 70% increase over the $3,581,250 reported for the six months ended August 31, 2006.  The increase is primarily due to increased headcount, primarily in direct sales, as we continue to build infrastructure to support a higher level of sales.  The increase also resulted from higher stock compensation expense attributable to the employment agreement entered into with our interim CEO, under which he is paid only in restricted stock and performance units.
 
Research & development expenses include employee compensation, stock options and depreciation and any related costs for personnel primarily focused on research and development efforts.  For the three months ended August 31, 2007 these costs were $783,298, a 175% increase over the $285,093 reported for the three months ended August 31, 2006.  R&D expenses for the six months ended August 31, 2007 were $1,582,048, a 193% increase over the $540,150 reported for the six months ended August 31, 2006. The increase in research and development expenses resulted primarily from increased headcount and increased third party expenses relating to the further development and enhancement of our TelvOS system.  The increase also resulted from increased headcount to maintain the Company’s existing systems and to provide customized support for our growing customer base.  However, we expect that these expenses will begin to decrease as a percentage of total revenues as we refocus our strategic direction on larger customers where customization expenses can be spread over a higher revenue base.
 
Liquidity and Capital Resources
 
Net cash used in operating activities was $5,557,029 for the six months ended August 31, 2007, compared to $1,755,910 for the six months ended August 31, 2006. The increase in cash used in operations was due primarily to an increase in our net loss.  Our net loss for the period increased significantly for the reasons described above.
 
Net cash used in investing activities was $1,725,248 for the six months ended August 31, 2007, compared to $659,676 for the six months ended August 31, 2006. This increase resulted primarily from additional capital expenditures needed to build out our CDN network.
 
Net cash provided by financing activities was $17,034,589 for the six months ended August 31, 2007, compared to $1,352,116 for the six months ended August 31, 2006.  The increase resulted from the sale of common stock on August 8, 2007 and the issuance of the Company’s 12% mandatorily convertible notes issued March 2, 2007 as described below.
 
We had $10,170,561 in cash and cash equivalents available at August 31, 2007 and available bank overdraft facilities of $60,411.
 
We have financed our operations from inception primarily through private sales of our equity and convertible debt securities. From inception through August 31, 2007, we issued an aggregate of 125,280,977 shares of our common stock for gross proceeds of approximately $31.8 million.  In addition, we have issued warrants in connection with certain of our fundraising activities and have granted options and issued shares in lieu of cash in payment to third parties for services rendered and in connection with the acquisition of Sportshows Television, Ltd. To a lesser extent, we have also used capital leases to fund some of our equipment acquisitions.  We have incurred significant losses since our inception and, at August 31, 2007, had an accumulated deficit of approximately $27.7 million.
 
An overdraft facility is a line of credit arrangement, negotiated with a bank and usually reviewable on an annual basis, whereby the bank's customer is permitted to take its checking account into a debit balance on a pre-agreed interest basis up to an agreed amount. Amounts utilized under overdraft facilities are payable on demand. At August 31, 2007 and February 28, 2007, the overdraft facilities consisted of $20,137 and $19,600, respectively, with Barclays Bank PLC and $40,274 and $39,000, respectively, with National Westminster Bank PLC (NatWest). Neither facility was utilized on August 31, 2007 or February 28, 2007. The interest rate on the Barclays facility is 5.75% above Barclays' variable base rate (which base rate was 5.25% per annum as of August 31, 2007). The interest rate on the NatWest facility is 5.75% above NatWest's variable base rate (which base rate was 5.25% per annum as of August 31, 2007). The Barclays overdraft facility was renewed on February 17, 2007.  The NatWest overdraft facility was renewed on May 31, 2007.
 
Our current ratio (current assets divided by current liabilities) relates to our ability to pay our short-term debts as they become due. At August 31, 2007, our current ratio was 5.7, compared to 0.9 at February 28, 2007. Our current ratio fluctuates primarily as we use cash to develop our business and raise additional funds from private financing from time to time.

8


NARROWSTEP INC. AND SUBSIDIARIES
 
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION .

On August 8, 2007, we closed a private financing with a number of accredited investors for the sale of common stock and warrants for a total purchase price of $10,510,000. Pursuant to the financing we sold a total of 42,040,000 shares of common stock at a purchase price of $0.25 per share. We also issued warrants to purchase an aggregate of 21,020,000 shares of common stock at an exercise price of $0.50 per share, subject to adjustment.  The warrants are exercisable at any time on or prior to August 8, 2012.  The warrants contain customary anti-dilution provisions in the event of any stock split, reverse stock split, reclassification or recapitalization of the Company.  In addition, the exercise price and the number of shares issuable upon the exercise of the warrants are subject to adjustment on a full-ratchet basis in the event that we issue or are deemed to have issued shares of common stock at an effective purchase price of less than $0.50 per share, subject to certain exceptions.  In the financing, we issued to the placement agents warrants to purchase an aggregate of 1,706,400 shares of common stock.  Those warrants have the same terms as the warrants issued in the financing, except that the warrants issued to the placement agents have a cashless exercise right.

On March 2, 2007, the Company entered into a Purchase Agreement (the “Purchase Agreement”) with sixteen accredited investors (the “Investors”) for the sale of its 12% Mandatorily Convertible Notes (the “Notes”) and Warrants (the “Warrants”) for a total purchase price of $7,110,000.  The Notes, which mature on March 2, 2009, bear interest at 12% per annum, payable at maturity.  The Notes will mandatorily convert at a 10% discount into the securities issued by the Company in any subsequent private placement that results in gross proceeds to the Company of at least $3,000,000 or, in the event of a sale of the Company prior thereto, shares of common stock valued at a discount of 10% to the per share price to be paid in the Company sale.  The Warrants are exercisable at any time on or prior to March 2, 2012 for an aggregate of 3,555,000 shares of common stock at an exercise price of $0.60 per share, subject to adjustment.  The Company has the right to force the cash exercise of the Warrants if the common stock trades at or above $1.80 per share for at least 20 consecutive trading days.  Both the Notes and the Warrants contain customary anti-dilution provisions in the event of any stock split, reverse stock split, reclassification or recapitalization of the Company.  In connection with the August 8, 2007 financing, the Company’s $7,110,000 in outstanding mandatorily 12% convertible notes were automatically converted into an aggregate of 35,392,003 shares of common stock at a conversion price of $0.225 per share.

With the completion of the August financing we believe that we have sufficient working capital to fund our operations for the next twelve months.  Management will continue to pursue various financing options in order to fully fund our longer term cash requirements.  We also are making efforts to improve our financial position by reducing ongoing operating expenses and continuing to focus on increasing sales.

As of August 31, 2007, our principal capital commitments consisted of obligations outstanding under capital leases as shown in the table below:


       
 
 
Six Months Ended
 
   
August 31, 2007
 
 
 
$
 
Amounts payable:
       
Within 12 months
   
180,021
 
Between one and two years
   
160,143
 
Between two and three years
   
75,400
 
Total future commitment
   
415,564
 
Less: finance charges allocated to future periods
    (47,151 )
Present Value
   
368,413
 

 
Off balance sheet arrangements      We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

9

 
NARROWSTEP INC. AND SUBSIDIARIES

ITEM 3. CONTROLS AND PROCEDURES
 
As of the end of the period covered by this report, the Company's management, with the participation of the Company's chief executive officer and chief financial officer, evaluated the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on such evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective as of August 31, 2007 to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms.
 
There have not been any changes in the Company's internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

On May 24, 2007, in connection with its audit of our consolidated financial statements for the year ended February 28, 2007, Rothstein, Kass & Company, P.C., our independent registered public accounting firm, informed us and our audit committee of certain deficiencies in our internal controls over financial reporting that they considered to be a material weakness and significant deficiencies. The material weakness was as follows:

 
·
We did not record the stock-based compensation expense on certain stock options, issued to one of our directors, on a timely basis. As a result of this, our third quarter interim financial statements were misstated.

The significant deficiencies were as follows:

 
·
We did not record a sufficient allowance for bad debts related to a customer’s accounts receivable balance that was in question.
     
 
·
We were recording invoices billed to certain customers in such a manner that the result was to recognize revenues on a cash basis, which is not in accordance with accounting principals generally accepted in the United States.

Inferior internal controls could harm our operating results or cause us to fail to meet our reporting obligations and could also cause our current and potential stockholders to lose confidence in our reported financial information, which could have a negative effect on the price of our stock.
 
In response to the deficiencies in our internal controls identified by Rothstein, Kass & Company, P.C. we restated our results for the fiscal third quarter ended November 30, 2006 and for the fiscal year ended February 28, 2007.  We have taken appropriate steps to correct these deficiencies in our internal controls identified by Rothstein, Kass & Company, P.C.
 
We will be documenting and testing our internal control procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. Pursuant to Section 404, beginning with our fiscal year ending February 29, 2008, we will be required to include in our annual report on Form 10-KSB a management assessment of the effectiveness of our internal controls over financial reporting.  For the fiscal year ending February 28, 2009, a report by our independent registered public accounting firm will be included opining on the operating effectiveness of our internal controls over financial reporting. We are exposed to increased costs associated with complying with these requirements, and will be spending management time and resources to document and test our internal controls in anticipation of Section 404 reporting requirements. In addition, we cannot assure you that we will not in the future identify material weaknesses or significant deficiencies in our internal controls over financial reporting that we have not discovered to date.
 
If we are not able to complete testing of all of our internal controls, or if during the course of our testing we identify deficiencies that we are not able to remediate in time, we and/or our independent registered public accounting firm may not be able to complete our/its respective assessments before the deadline for compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. If we fail to timely complete our evaluation and testing in order to allow for the assessment by our management, or if our independent registered public accounting firm cannot timely attest to our management's assessment, we could be subject to regulatory scrutiny and a loss of public confidence in our internal controls, which could harm our business and our stock price. Further, if our independent registered public accounting firm is not satisfied with our internal controls over financial reporting or with the level at which they are documented, designed, operated or reviewed, it may decline to opine on the operating effectiveness of our internal controls over financial reporting or may issue a qualified report identifying significant deficiencies and / or material weakness in our internal controls. This could result in significant additional expenditures responding to the Section 404 internal control audit, a diversion of management attention and a decline in our stock price.
 
10

 
NARROWSTEP INC. AND SUBSIDIARIES
 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This report contains forward-looking statements including, without limitation, in the discussion under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operations." Any and all statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Terms such as may, might, would, should, could, project, estimate, pro forma, predict, potential, strategy, anticipate, attempt, develop, plan, help, believe, continue, intend, expect, future, and similar terms and terms of similar import (including the negative of any of the foregoing) may be intended to identify forward-looking statements. However, not all forward-looking statements may contain one or more of these identifying terms. Forward-looking statements in this report may include, without limitation, statements regarding (i) a projection of revenues, income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure, or other financial items, (ii) the plans and objectives of management for future operations, including plans or objectives relating to our products or services,  (iii) our future financial performance, including any such statement contained in a discussion and analysis of financial condition by management or in the results of operations included pursuant to the rules and regulations of the Securities and Exchange Commission, and (iv) the assumptions underlying or relating to any statement described in subparagraphs (i), (ii), or (iii).
 
The forward-looking statements are not meant to predict or guarantee actual results, performance, events, or circumstances and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates, and assumptions and are subject to a number of risks and uncertainties and other influences, many of which we have no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, our inability to obtain adequate financing, insufficient cash flows and resulting illiquidity, our dependence upon significant customers, our inability to expand our business, government regulations, increased competition, changing customer preferences, stock illiquidity, failure to implement our business plans or strategies, and ineffectiveness of our marketing program and our acquisition opportunities. A description of some of the risks and uncertainties that could cause our actual results to differ materially from those described by the forward-looking statements in this report appears under the caption "Risk Factors" and elsewhere in the most recent Registration Statement on Form SB-2 and Form 10-KSB that we have filed with the Securities and Exchange Commission.
 
Because of the risks and uncertainties related to these factors and the forward-looking statements, readers are cautioned not to place undue reliance on the forward-looking statements. We disclaim any obligation to update these forward-looking statements or to announce publicly the results of any revisions to any of the forward-looking statements contained in this report to reflect any new information or future events or circumstances or otherwise unless required to do so under applicable federal securities laws.
 
Readers should read this report and the following discussion and analysis in conjunction with the financial statements and the related notes contained in this report and the other documents we file from time to time with the Securities and Exchange Commission.
 

PART II - OTHER INFORMATION

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
Reference is hereby made to the Company’s Current Report on Form 8-K filed on August 10, 2007 for certain information relating to the sale of common stock and warrants for a total purchase price of $10,510,000 and the related conversion of the Company’s previously issued mandatorily convertible notes.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
Annual Meeting of Shareholders

 
(a)
The annual meeting of the shareholders of Narrowstep Inc. was held on September 28, 2007, in Princeton, New Jersey.  Shareholders representing 100,517,139, 80% of the common shares outstanding as of the August 10, 2007 record date, were present in person or represented by proxies at the meeting.
 
(b)
Election of Directors:

       
 
 
VOTES
 
 
Nominee
For
   
Withheld*
 
 
David McCourt
 
95,426,769
     
5,090,370
 
 
Iolo Jones
 
90,833,045
     
9,684,094
 
 
Rajan Chopra
 
95,597,629
     
4,919,510
 

11



*Includes shares represented at the meeting by proxy where the shareholders withheld authority to vote for the indicated Director or Directors, as well as shares present at the meeting that were not voted for such Director or Directors.

 
(c)
In addition to the Directors elected above, Jack Whyte, and Roger Werner continue as Directors.
 
(d)
Holders of common shares voted at this meeting on the following matters, which were set forth in our proxy statement:

       
 
 
VOTES
 
   
For
   
For %
   
Against
   
Against %
   
Abstain
   
Non-vote
 
Amend Certificate of Incorporation to clarify certain provisions relating to the terms of office of directors
   
95,590,119
     
76.3%
     
3,661,181
     
2.9%
     
1,265,839
     
24,763,838
 

Percentages are based on the total number of Common shares outstanding as of the record date of the meeting.

12



 
 

 

ITEM 6. EXHIBITS
 

 
 
EXHIBIT 31.1
CERTIFICATION FILED PURSUANT TO EXCHANGE ACT RULES 13a-14 AND 15d-14 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
     
 
EXHIBIT 31.2
CERTIFICATION FILED PURSUANT TO EXCHANGE ACT RULES 13a-14 AND 15d-14 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
     
 
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     
 
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


13


 
SIGNATURES
 
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
NARROWSTEP INC.
 
 
 
 
    By: /s/ David McCourt  
Dated:  October 15, 2007     David McCourt  
      Interim Chief Executive Officer  
         
         
    By: /s/ Lisa VanPatten  
Dated:  October 15, 2007     Lisa VanPatten  
      Chief Financial Officer  
 
 
14


 
 
 

 
 
Narrowstep (CE) (USOTC:NRWS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Narrowstep (CE) Charts.
Narrowstep (CE) (USOTC:NRWS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Narrowstep (CE) Charts.